Vol. 2025 No. 4 (2025)
Articles

The effect of rAd-p53+cisplatin on gastric cancer cell growth and KAI1/CD82 expression

PDF
  • Da-eun Shin
Da-eun Shin
Pohang University of Science and Technology,77 Cheongam-ro, Nam-gu, Pohang, Gyeongsangbuk-do, 37673, South Korea

Published 18-09-2025

Keywords

  • Recombinant human P53,
  • Adenovirus injection,
  • SGC7901,
  • KAI1/CD82

Copyright (c) 2025 Cambridge Science Advance

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

How to Cite

[1]
D.- eun Shin, “The effect of rAd-p53+cisplatin on gastric cancer cell growth and KAI1/CD82 expression”, Camb. Sci. Adv., vol. 2025, no. 4, pp. 26–31, Sep. 2025, doi: 10.62852/csa/2025/176.

Abstract

Objective To investigate the effects of rAd-p53 and cisplatin (DDP)alone or in combination on the proliferation, apoptosis, and KAI1/CD82 protein expression of human gastric cancer SGC7901 cells. Methods SGC7901 cells were treated with rAd-p53, DDP, or their combination for 24,48, and 72 hours. The proliferation activity of SGC7901 cells was measured using the CCK-8 assay. Apoptosis rates were determined by flow cytometry, and the expression of KAI1/CD82 protein was detected by immunohistochemistry. Results Both rAd-p53 and DDP alone, as well as their combination, inhibited the proliferation of SGC7901 cells in a dose-and time-dependent manner. The proliferation inhibition rate of the combination group was significantly higher than that of the single-agent groups, with statistically significant differences compared to the negative control group(P<0.05).After 48 hours of treatment with rAd-p53,DDP,or their combination, the apoptosis rates were 36.94%±0.78%,28.79%±2.37%,and 69.26%±0.63%,respectively,all of which were significantly higher than that of the negative control group(16.72%±1.54%,P<0.05).Both rAd-p53 and DDP alone, as well as their combination, upregulated the expression of KAI1/CD82 protein, with the combination group showing the most significant increase. Conclusion Both rAd-p53 and DDP alone, as well as their combination, can inhibit the growth of gastric cancer SGC7901 cells and induce apoptosis. The combination of the two drugs enhances the inhibitory effect on gastric cancer cells. rAd-p53 may induce apoptosis in SGC7901 cells by upregulating the expression of KAI1/CD82, thereby enhancing the antitumor effect of DDP.

PDF

References

  1. Achison M, Hupp TR. Hypoxia attenuates the p53 response to cellular damage〔J〕. Oncogene, 2003, 22(22):3431-3440.
  2. Karim S, Mirza Z, Naseer MI. Clinicopathollgical characteristics and chronology of p53 expression in the development of gastric cancer〔J〕. Hepatogastroenterology, 2013, 60(128): 2113-2118.
  3. Peng Z. Current status of Gendicine in China: recombinant human Ad-p53 agent for treatment of cancers〔J〕. Hum Gene Ther, 2005,16(9):1016-1027.
  4. Ueda T, Ichikawa T, Tamaru J, et al. Expression of the KAI1 protein in benign prostatic hyperplasia and prostate cancer〔J〕. Am J Pathol,1996,149(5):1435-1440.
  5. Yang JM, Peng ZH, Si S H, et al. KAI1 gene suppresses invasion and metastasis of hepatocellular carcinoma MHCC97-H cells in vitro and in animal model〔J〕. Liver Int, 2008,28(1):132-139.
  6. Monti P, Ciribilli Y, Jordan J, et al. Transcriptional functionality of germline p53 mutants influences cancer phenotype〔J〕. Clin Cancer Res,2007,13(13):3789-3795.
  7. Kenig S, Frangez R, Puce r A, et al. Inhibition of cathepsin L Lowers the apoptotic threshold of gliblastoma cells by upregulating p53 and transcription of caspases 3 and 7〔J〕. Apoptosis, 2011, 16(7); 671-682.
  8. Zhu L, Lu Z, Zhao H. Antitumor mechanisms when p Rb and p53 are genetically inactivated〔J〕. Oncogene, 2015,34(35):4547-4557.
  9. Li Y, LI B, LI CJ.et al. Key points of basic theories and clinical practice in rAd-p53 (Gendicine?) gene therapy for solid malignant tumors〔J〕. Expert O pin Biol, 2015,15(3):437-454.
  10. Li Q, Zhang H, Tan C, et al. AdHu5-apoptin induces G₂/M arrest and apoptosis in p53-mutated human gastric cancer SGC-7901 cells〔J〕. Tumour Biol,2013,34(6):3569-3577.
  11. Liu W M, Zhang X A. KAI1/CD82, an tumor metastasis suppressor〔J〕. Cancer Lett, 2006, 240:183-194.
  12. Bari R, Zhang YH, Zhang F, et al. Transmembrane interactions are needed for KAI1/CD82 mediated suppression of cancer invasion and metastasis〔J〕. Am J Pathol,2009,174(2):647-660.
  13. Guo C, Liu Q G, Zhang L, et al. Expression and clinical significance of p53 JunB and KAI1/CD82 in human hepatocellular carcinoma〔J〕. Hepatobiliary Pancreat Dist Int,2009,8(4):389-396.
  14. Mashimo T, Bandyopadhyay S, Goodarzi G, et al. Activation of the tumour metastasis suppressor gene, K A Il by etoposide is mediated by p53 and c-Jun genes[J]. Biochem Bio-phys Res Com,2000,274(11):370-376.